PMID- 34673590 OWN - NLM STAT- MEDLINE DCOM- 20220201 LR - 20220427 IS - 0974-5130 (Electronic) IS - 0377-4929 (Linking) VI - 64 IP - 4 DP - 2021 Oct-Dec TI - Expression of TLE1, INI1, beta-catenin, Claudin1, CK7, CK19, SS18 and calponin in synovial sarcoma. PG - 707-716 LID - 10.4103/IJPM.IJPM_1137_20 [doi] AB - BACKGROUND AND OBJECTIVES: Synovial sarcomas (SS) are enigmatic soft tissue tumors, which are yet to have a defined cell of origin. SS have a variety of differential diagnosis depending upon the age of the patient and the site of presentation. This makes diagnosis cumbersome unless the specific fusion SS18:SSX is identified by reverse transcription-polymerase chain reaction (RT-PCR) or fluorescence in situ hybridization (FISH). Immunohistochemistry is a useful tool in resource-poor settings in helping to narrow the differentials and help diagnose this tumor. This study set about assessing possible candidate immunohistochemical markers in their utility to recognize SS. METHODS: Forty cases of SS, proven by FISH were included. A tissue microarray (TMA) was constructed, and immunohistochemistry was done using antibodies - TLE1 (OTI1F5), beta-catenin (14), INI1 (MRQ-27), CK7 (OV-TL), CK19 (polyclonal), SS18 (polyclonal), calponin (CALP), and claudin1 (Polyclonal). The expression was analyzed to arrive at sensitivity and specificity. RESULTS: TLE1 had a sensitivity of 92.5% and a specificity of 100%; beta-Catenin had a sensitivity of 17.5% and specificity of 100%; Calponin had a sensitivity of 97.5% and a specificity of 81.25%; SS18 had a sensitivity of 95% and specificity of 100%; INI1 had a sensitivity of 95% and specificity of 100%; CK7 had a sensitivity of 90% and specificity of 87.5%; CK19 had a sensitivity of 90% and a specificity of 59.38%; and Claudin had a sensitivity of 85% and a specificity of 78.12%. INTERPRETATION AND CONCLUSIONS: The study showed both TLE1 and SS18 are robust diagnostic markers of synovial sarcoma with a sensitivity of 92% and 95%, respectively. INI1 can be used to discriminate SS from nonepithelioid and nonrhabdoid differentials. Calponin expression is helpful to differentiate poorly differentiated SS from its mimics. CK7 is a better marker than CK19 and can be used as a replacement for EMA in the initial screening panel. The use of claudin1 was restricted to delineating the epithelial component. beta-Catenin had poor sensitivity, restricting its utility in SS. FAU - Madakshira, Manoj Gopal AU - Madakshira MG AD - Department of Histopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India. FAU - Radotra, Bishan Dass AU - Radotra BD AD - Department of Histopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India. FAU - Kaman, Lileswar AU - Kaman L AD - Department of General Surgery, Post Graduate Institute of Medical Education and Research, Chandigarh, India. FAU - Saikia, Uma Nahar AU - Saikia UN AD - Department of Histopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India. LA - eng PT - Comparative Study PT - Journal Article PL - India TA - Indian J Pathol Microbiol JT - Indian journal of pathology & microbiology JID - 7605904 RN - 0 (Biomarkers, Tumor) RN - 0 (Calcium-Binding Proteins) RN - 0 (Co-Repressor Proteins) RN - 0 (Microfilament Proteins) RN - 0 (beta Catenin) SB - IM MH - Adolescent MH - Adult MH - Age Factors MH - Aged MH - Aged, 80 and over MH - Biomarkers, Tumor/genetics/metabolism MH - Calcium-Binding Proteins/*genetics MH - Child MH - Co-Repressor Proteins/*genetics/metabolism MH - Female MH - Gene Expression Regulation, Neoplastic MH - Humans MH - Male MH - Microfilament Proteins/*genetics/metabolism MH - Middle Aged MH - Prospective Studies MH - Retrospective Studies MH - Sarcoma/diagnosis/genetics/physiopathology MH - Sarcoma, Synovial/*diagnosis/*genetics/*physiopathology MH - Young Adult MH - beta Catenin/*genetics/metabolism OTO - NOTNLM OT - Beta-catenin OT - CK19 OT - CK7 OT - Claudin1 OT - INI1 OT - SS18 OT - TLE1 OT - calponin OT - immunohistochemistry OT - synovial sarcoma EDAT- 2021/10/22 06:00 MHDA- 2022/02/02 06:00 CRDT- 2021/10/21 21:10 PHST- 2021/10/21 21:10 [entrez] PHST- 2021/10/22 06:00 [pubmed] PHST- 2022/02/02 06:00 [medline] AID - IndianJPatholMicrobiol_2021_64_4_707_328519 [pii] AID - 10.4103/IJPM.IJPM_1137_20 [doi] PST - ppublish SO - Indian J Pathol Microbiol. 2021 Oct-Dec;64(4):707-716. doi: 10.4103/IJPM.IJPM_1137_20.